Okay, let's tackle this question about treating maternal toxoplasmosis at 16 weeks. First, I need to recall the standard treatment protocols for toxoplasmosis during pregnancy. Toxoplasma gondii can be transmitted to the fetus, leading to congenital toxoplasmosis, which can cause serious complications like hydrocephalus or chorioretinitis. The key here is to determine the appropriate medication for the mother to reduce the risk of transmission.

The core concept here is the management of acute Toxoplasma infection in pregnant women. The treatment aims to prevent or reduce fetal infection. The correct treatment would depend on the gestational age. I remember that in the first trimester, pyrimethamine might be avoided due to teratogenic risks, but in the second and third trimesters, it's considered safer. The standard regimen in the second trimester (like 16 weeks) is usually a combination of pyrimethamine and sulfadiazine, along with leucovorin to mitigate side effects.

Now, the options are missing, but common incorrect options might include drugs like spiramycin, which is used in the first trimester but less effective later. Another possible wrong option could be a drug like clindamycin, which isn't typically used for toxoplasmosis. Also, some might confuse it with treatments for other infections like chlamydia or syphilis.

So, the correct answer would be a combination of pyrimethamine and sulfadiazine. I should explain why this is the case, mention the role of leucovorin, and clarify why other options are incorrect. The clinical pearl here is to remember the trimester-specific treatment guidelines for toxoplasmosis to avoid teratogenic agents in the first trimester and use the appropriate regimen in later stages.

**Core Concept**
Toxoplasma gondii infection during pregnancy requires treatment to reduce fetal transmission risk. The therapeutic approach varies by gestational age, with pyrimethamine-based regimens used in the second trimester to prevent congenital toxoplasmosis.

**Why the Correct Answer is Right**
Pyrimethamine (a dihydrofolate reductase inhibitor) combined with sulfadiazine and leucovorin is the standard treatment for maternal toxoplasmosis in the second trimester (16 weeks). Pyrimethamine inhibits parasite nucleic acid synthesis, while sulfadiazine targets dihydropteroate synthase. Leucovorin is added to prevent maternal folate deficiency. This regimen is initiated after 16 weeks due to pyrimethamine’s teratogenicity in the first trimester.

**Why Each Wrong Option is Incorrect**
**Option A:** Spiramycin is reserved for first-trimester infection but has poor placental penetration in later gestation.
**Option B:** Clindamycin lacks efficacy against Toxoplasma.
**Option C:** Doxycycline is contraindicated in pregnancy due to fetal bone/tooth toxicity.

**Clinical Pearl / High-Yield Fact**
Never use pyrimethamine before 14 weeks (teratogenic risk). In the second/third trimester, pyrimethamine + sulfadiazine + leucovorin is gold standard

✓ Correct Answer: A. Spiramycin